Literature DB >> 25140397

Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts.

Emil Hagström1, Lena Kilander, Ruta Nylander, Elna-Marie Larsson, Karl Michaëlsson, Håkan Melhus, Håkan Ahlström, Lars Johansson, Lars Lind, Johan Arnlöv.   

Abstract

CONTEXT: In diseases with increased PTH such as hyperparathyroidism and chronic renal failure, dementia is common. Little is known of PTH and dementia in the community.
OBJECTIVE: We sought to investigate relations between PTH, clinical dementia and cerebral micro-vascular disease. SETTING AND
DESIGN: The Uppsala Longitudinal Study Of Adult Men (ULSAM) was prospective, baseline, 1991-1995; followup, 15.8 years. The Prospective Investigation Of The Vasculature In Uppsala Seniors (PIVUS) was cross-sectional, baseline, 2001. Both settings were community based. PARTICIPANTS AND MAIN OUTCOME MEASURE: In the ULSAM study of 998 men (age 71) the association between PTH and dementia was investigated. In the PIVUS study of 406 men and women (age 70) the relation between PTH and magnetic resonance imaging signs of cerebral small vascular disease was investigated.
RESULTS: During followup, 56 individuals were diagnosed with vascular, 91 with Alzheimer's, and 59 with other dementias. In Cox-regression analyses, higher PTH was associated with vascular dementia (hazard ratio per 1 SD increase of PTH, 1.41; P < .01), but not with other dementias. The top tertile of PTH accounted for 18.5% of the population-attributable risk for vascular dementia, exceeding all other risk factors. In linear regression analysis in PIVUS, PTH was associated with increasing white matter hyperintensities (WMHI), reflecting increasing burden of cerebral small vessel disease (1 SD PTH increase, 0.31 higher category of WMHI; P = .016). All models were adjusted for vascular risk factors and mineral metabolism.
CONCLUSIONS: In two community-based samples, PTH predicted clinically diagnosed vascular dementia as well as neuroimaging indices of cerebral small vessel disease. Our data suggest a role for PTH in the development of vascular dementia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25140397     DOI: 10.1210/jc.2014-1736

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Reduced deep regional cerebral venous oxygen saturation in hemodialysis patients using quantitative susceptibility mapping.

Authors:  Chao Chai; Saifeng Liu; Linlin Fan; Lei Liu; Jinping Li; Chao Zuo; Tianyi Qian; E Mark Haacke; Wen Shen; Shuang Xia
Journal:  Metab Brain Dis       Date:  2017-12-16       Impact factor: 3.584

2.  Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.

Authors:  Ammar Asban; Alex Dombrowsky; Reema Mallick; Rongbing Xie; James K Kirklin; Raymon H Grogan; David F Schneider; Herbert Chen; Courtney J Balentine
Journal:  Oncologist       Date:  2019-04-24

Review 3.  Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.

Authors:  Weifan Xu; Yiping Jiang; Nani Wang; Huanhuan Bai; Shengyan Xu; Tianshuang Xia; Hailiang Xin
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

4.  Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.

Authors:  M Li; F Lv; Z Zhang; W Deng; Y Li; Z Deng; Y Jiang; O Wang; X Xing; L Xu; W Xia
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

5.  Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study.

Authors:  Sai Krishna C Korada; Di Zhao; Rebecca F Gottesman; Eliseo Guallar; Pamela L Lutsey; Alvaro Alonso; A Richey Sharrett; Wendy S Post; Jared P Reis; Thomas H Mosley; Erin D Michos
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-01-26       Impact factor: 2.136

6.  Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.

Authors:  Yan Yu; Ming Bai; Zhang Wei; Lijuan Zhao; Yangping Li; Feng Ma; Shiren Sun
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 7.  Mechanisms of cognitive dysfunction in CKD.

Authors:  Davide Viggiano; Carsten A Wagner; Gianvito Martino; Maiken Nedergaard; Carmine Zoccali; Robert Unwin; Giovambattista Capasso
Journal:  Nat Rev Nephrol       Date:  2020-03-31       Impact factor: 28.314

8.  Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer's Disease: A Mendelian Randomization Study.

Authors:  Susanna C Larsson; Matthew Traylor; Hugh S Markus; Karl Michaëlsson
Journal:  Nutrients       Date:  2018-09-06       Impact factor: 5.717

9.  High-Phytate Diets Increase Amyloid β Deposition and Apoptotic Neuronal Cell Death in a Rat Model.

Authors:  Hyo-Jung Kim; Yun-Shin Jung; Yun-Jae Jung; Ok-Hee Kim; Byung-Chul Oh
Journal:  Nutrients       Date:  2021-12-06       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.